Bridging Interventional Development Gaps (BrIDGs) provides eligible scientists with no-cost access to contractor services, such as toxicology studies, for pre-clinical therapeutic development. BrIDGs is now housed in the National Center for Advancing Translational Sciences (NCATS).
Visit: http://www.ncats.nih.gov/research/rare-diseases/bridgs/bridgs.html for more information.
Schematic for BrIDGs Concept
Where private sector capacity for drug development is limited or not available, the NIH can help to bridge the gap by providing resources needed to facilitate development of promising therapies
This page last reviewed on May 8, 2017